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In 2002, in a judgment relating to the use of the morning-after pill, Mr 
Justice Munby held that pregnancy begins with the implantation of an 
embryo into the uterus of a woman. The case involved a large body of 
expert witness evidence including medical and physiological details of 
human reproduction. Munby J. emphasised one particular aspect of 
this evidence: namely, the developmental failure rate of human 
embryos after fertilisation. Under natural conditions, embryo loss is 
approximately 10-40% before implantation, and total loss from 
fertilisation to birth is 40-60% (Jarvis, 2016). By contrast, and based on 
expert witness testimony, Munby J. stated that not much more than 
25% of successfully fertilised eggs reach the implantation stage, and 
that fewer than 15% of fertilised eggs result in a birth, figures that do 
not accurately represent scientific knowledge regarding human 
embryo mortality and pregnancy loss under natural conditions. 
Rather, these figures were derived from experimental laboratory data 
and clinical outcomes from in vitro fertilisation treatment. Testimony 
provided by other expert witnesses directly contradicted these specific 
numerical claims. In emphasising these figures, Munby J. gave the 
impression that human embryo mortality is substantially higher than 
available scientific evidence indicated. In this critique, all the scientific 
expert witness evidence is presented and reviewed, and an 
explanation provided for why the emphasised figures are wrong. 
Whether there are implications of Munby J.’s scientific misjudgment 
on the legal outcome is for others to consider.
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Introduction
In 2002, a judicial review was considered by the Honourable 
Mr Justice Munby of the Queen’s Bench Division (Adminis-
trative Court) to determine whether the supply of Levonelle 
(commonly referred to as a morning-after pill (MAP)) by 
pharmacists amounted, in principle, to a criminal act under 
section 58 and/or section 59 of the Offences against the 
Person Act 18611,a. Counsel for the claimant argued that the 
MAP could act by preventing the implantation of a fertilised 
egg in the uterus and that its use for this purpose therefore 
constituted an act intended to bring about a miscarriage. 
Counsel argued that the supply and use of the MAP for 
this purpose ought therefore to be regulated in the same way as 
surgically- or medically-induced abortion, as required by the 
Abortion Act 1967. A judgment in favour of the claimant 
would have had a significant social impact on the supply of the 
MAP.
The Claimant was John Smeaton, on behalf of the Society for 
the Protection of Unborn Children (SPUC). The Defendant was 
The Secretary of State for Health, and the two Interested 
Parties were Schering Health Care Ltd and the Family Planning 
Association.
Munby J. held that “the prescription, supply, administration 
or use of the morning-after pill does not – indeed cannot 
– involve the commission of any offence under either section 58 
or section 59 of the 1861 Act”b.
The case included evidence from scientific expert witnesses and 
in his judgment, which Munby J. conceded was “necessarily 
very long”c, he described and scrutinised aspects of this 
evidence in detail.
The primary purpose of this article is to shed light upon one 
aspect of the scientific expert witness evidence, uncritically 
accepted and deliberately emphasised by Munby J., which 
was inaccurate and glaringly inconsistent: namely, the extent of 
natural embryo mortality in humans in the first week after 
fertilisation. The nature of the error, the inconsistencies in the 
expert evidence, and their sources are reviewed and explained.
Whether any legal implications arise from the inconsistent 
expert witness testimony and judicial error is for others to 
consider.
Expert witness statements
Copies of original expert witness statements used in this 
critique were made available freely on request from the 
archives of the Claimant. Civil Procedure Rules concerning 
the use of witness statements for other purposes indicate 
that where a witness statement has been put in evidence at a 
hearing held in public, its use is not restricted to the purpose of 
the proceedings in which it is servedd. Regarding subsequent 
use of disclosed documents: they may be used only for the 
purpose of the proceedings in which they are disclosed, 
except where they have been read to or by the court, or referred 
to, at a hearing that has been held in publice. The substantive 
hearing was held in public and lasted three days, starting on 
12th February 2002f. All witness statements referred to in this 
article were read and referred to by Munby J. No court order 
has been made restricting or prohibiting the use of these expert 
witness statements. Finally, it is in keeping with principles of 
open justice (and academic enquiry) that evidence placed before 
courts be available for public scrutiny, as confirmed in recent 
case law2.
A full transcript (redacted of personal information) of all 
these statements is available on request from the author. In 
producing the transcript from original copies of court papers, 
every effort has been made to reproduce the content as 
accurately as possible. Errors and idiosyncrasies in spelling, 
grammar and style have been retained. Any errors of transcrip-
tion are entirely the responsibility of this author, and will be 
corrected on notification. Where consent to publish has been 
obtained from the witnesses, full transcripts are directly 
available in the Underlying data3 as described in the Data 
availability section. Where consent to publish has not been 
obtained, only those passages quoted by Munby J. or directly 
referenced in this article are shown, the remainder being 
redacted. Transcripts are intended to enable readers to draw their 
own conclusions about the contents of the judgment and this 
article.
The scientific and/or medical expert witness statements 
were provided to the court by eight “very eminent medical 
experts”g as summarised in Table 1. Munby J. commended 
submissions from all parties, both written and oral, as being 
“uniformly of the very highest quality”h. However, although 
Munby J. stated that “they were all agreed as to the basic 
physiology”i, close reading indicates that, with regard to the 
extent of embryo mortality, this was not the case.
The incidence of natural human embryo mortality
Before proceeding, it will be helpful to summarise the key 
biological stages in normal early human reproduction: coitus, 
ovulation, fertilisation, embryo development and implantation. 
Munby J. does a commendable job of synthesising the 
biological evidence in paragraph 126 of his judgment. Coitus 
introduces sperm into the lower female reproductive tract and 
ovulation releases an egg into the upper female reproductive 
a Paragraphs from the judgment (and witness statements) are referenced in footnotes 




d The Civil Procedure Rules, r.32.12(2)(c)
e The Civil Procedure Rules, r.31.22(1)(a)
f Munby [32].
g Munby [125] & [191].
h Munby [32].
i Munby [126].
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tract. Fertilisation occurs in the fallopian tube when sperm 
and egg meet and one sperm penetrates the egg: “This can be 
described as Time 0”j. The fertilised egg develops and becomes 
a blastocyst after 5–6 days. Around day 7, the blastocyst begins 
to implant into the lining of the uterus. During implantation, 
the embryo produces human chorionic gonadotrophin (hCG), 
detection of which “represents the first reliable opportunity to 
identify the existence of an embryo”k. Approximately 2 weeks 
after fertilisation, a woman will miss her menstrual period, the 
first clear external indication of the presence of a developing 
embryo.
Complex biologic processes do not work perfectly all of the 
time, including human reproduction. A recent re-analysis has 
concluded that pre-implantation embryo loss is approximately 
10–40% and that total loss from fertilisation to birth is 
approximately 40–60%4. In addition, a review of scientific data 
that contribute to quantitative claims regarding natural pregnancy 
loss provides a detailed background against which claims 
made by the expert witnesses regarding the incidence of natural 
human embryo mortality may be evaluated5. Making sense of 
these numerical estimates is not easy. To aid understanding, 
Figure 1 summarises conclusions from these articles alongside 
the claims of the expert witnesses and numerical estimates 
from an influential and valuable analysis by Henri Leridon6. 
Details of how the figure was constructed are in the legend.
Four of the eight expert witnesses provided numerical 
estimates and/or comment on the extent of human embryo 
mortality: Drife, Brown, Braude and McLean. It is in these 
quantitative claims regarding embryo mortality that an incon-
sistency in the evidence and a judicial error of interpretation is 
apparent. I shall consider each witness statement in turn and then 
Figure 1. Estimates of embryo survival from fertilisation until (A) birth or (B) four weeks after fertilisation. Numerical values derived directly 
from witness statements are shown as solid points. Open points have been inferred to facilitate graphical representation. Two sets of reference 
values have been included for comparison. The first set is derived from Table 3 of Jarvis (2016) by averaging probabilities from three 
independent studies. The second is from Table 4.20 of Leridon (1977). The figure clearly indicates that the extent of early embryo mortality 
obtained from Braude (PB/2) and emphasised by Munby J. in his judgment is substantially different from all the other witness statement 
estimates and those published by Jarvis and Leridon. Drife’s estimate for total pregnancy loss from fertilisation to birth is also excessive 
compared to the other values. The explanation for the large discrepancy in pre-implantation mortality is that Braude’s estimate is derived from 
in vitro laboratory and clinical IVF data, and not from natural reproduction.
j Munby [126(iii)].
k Munby [126(ix)].
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explain the nature and source of the scientific error in Munby J.’s 
judgment.
A. Professor James Owen Drife
Professor Drife’s witness statement (WSJD, see Underlying 
data) was quoted verbatim and at length by Munby J.l, including 
the following section, which summarises numerically the fate of 
fertilised embryos: 
“From various strands of evidence it has been calculated 
that in a normally cycling woman who is sexually active and 
not using contraception, conception will occur in about 
85% of cycles. Of those fertilised eggs, around 15% will be 
lost before implantation begins. Of those which begin to 
implant, only about half will implant successfully. Of the 
half which do implant successfully (as shown by detectable 
HCG in the woman’s urine), between one third and one half 
will be lost at the time of the menses. Overall, therefore, 
around 75% of all conceptions are followed by an apparently 
normal period.1”m
In the original witness statement, this passage includes a 
citation (Footnote 1, shown above) to a short (approx. 280 
words) article7 published by Drife over 18 years previously 
in the British Medical Journaln. This brief article, entitled 
What proportion of pregnancies are spontaneously aborted? 
contains four citations. The first two are reviews by Short8 
and Schlesselman9 that draw their quantitative conclusions 
ultimately from the same primary sources: namely, the unique 
anatomical studies of Arthur Hertig10, and French & Bierman’s 
observational study of 3,197 pregnancies in Kauai in the 
1950s11. Henri Leridon, a renowned epidemiologist, used 
these same data to produce a complete life table for intra- 
uterine mortality in 19776. Leridon’s review has been widely 
cited (although not directly by Short) and his life table is 
reproduced as Table II in Schlesselman’s review. Strangely, 
despite using the same sources, Short concludes that “only 
about 47% of conceptions will result in a full-term live birth”8 
whereas Leridon’s estimate is 37% (31/84)6. Drife’s third 
citation is a brief article in The Lancet by Roberts & Lowe, 
which concludes that 78% of all fertilised eggs perish before 
birth12. The fourth citation is a report by Miller et al. (1980) 
of a prospective study of 197 women13, estimating the loss of 
implanted embryos before clinical recognition of pregnancy, 
i.e., embryo loss between 1 and 2 weeks post-fertilisation.
These sources have been critically reviewed5. In summary: 
(1) Hertig’s quantitative estimates are highly imprecise; 
(2) French & Bierman’s study provides no relevant data regard-
ing embryo loss during the two weeks after fertilisation; 
(3) Roberts & Lowe’s conclusions are derived from speculative 
arithmetic and have no practical quantitative value; (4) when 
compared to subsequent studies, Miller’s estimate of 43% loss 
from implantation to birth (cited by Drife) is almost certainly an 
overestimate.
The quantitative accounts in WSJD and the brief BMJ article 
partially follow Leridon (see Figure 1). The 85% fertilisa-
tion rate matches Leridon’s 84%, and derives ultimately from 
Hertig14. The pre-implantation loss of 15% is also similar to 
Leridon’s. There are however, some inconsistencies between 
Drife’s two accounts. For example, in the BMJ article he 
closely follows Leridon in stating that 15 fertilised ova 
fail to implant (i.e., 15/85 = 18%), but reports this as 15% 
(i.e., 15/100 = 15%) in WSJD. Furthermore, the conclusion 
in his witness statement that “75% of all conceptions are 
followed by an apparently normal period”o does not match the 
claim published in the BMJ that “the proportion of pregnan-
cies lost after conception is 76%”p, and substantially differs from 
Leridon’s estimate for embryo loss before a normal period 
of 50%. This is principally because of the addition of an extra 
stage of loss between implantation and the first missed period 
(Figure 1). Hence, Drife overstated (perhaps inadvertently) 
the extent of early embryo mortality in his witness statement 
compared to both his own published article and the most 
authoritative source on which he relied.
In his 1983 BMJ article, Drife cited Miller et al. (1980) who 
probably exaggerate early pregnancy loss5. However, in 2001, 
the date of the witness statement, at least eight relevant studies 
on early embryo mortality had been published5, including a 
seminal work by Wilcox et al. (1988)15. An expert witness might 
have been expected to refer to some or all of these works.
This consideration of Drife’s expert testimony highlights four key 
points: 
1.     Drife had written and published little on the subject of 
human embryo mortality.
2.     Published claims regarding human embryo mortality are 
scant, confusing and contradictory.
3.     Drife’s claim that 15% of embryos are lost in the first 
week after fertilisation before implantation is drawn 
from Leridon’s widely known and respected review of 
embryo mortality.
4.     Drife’s claim that 75% of all embryos are lost before 
an apparently normal period is an exaggeration that 
contradicts both Leridon’s account and his own published 
article!
l Munby [131-5] & [137]; WSJD [3-4], [8], [11-12] & [16].
m Munby [134]; WSJD [8]. Footnote 1 (shown at the end of the quotation) is found 
in WSJD but omitted from the judgment, and reads as follows: “1 Drife, JO. British 
Medical Journal 1983; 286:294.”
n The BMJ has no record of whether this response to a reader question (or similar 
short items) would have been peer-reviewed in 1983 (personal email correspondence 
from BMJ editorial office, 23rd June 2020).
o WSJD [8]. This claim only makes sense if his estimate of post-implantation loss 
of ‘between one third and one half’ is interpreted as 42% (average of 33% and 
50%). However, in his BMJ piece, Drife states that out of 36 women with detect-
able hCG, only 24 will miss a period, indicating a loss at this stage of 12/36 = 33%. 
Thus, his estimate of post-implantation loss is inflated in WSJD compared to the 
BMJ.
p The BMJ figure incorporates an estimate (‘between 10% and 30%’) for the rate 
of pregnancy loss after a woman knows she is pregnant. To be internally consistent 
in the BMJ piece, a clinical pregnancy failure rate of 15% must be used. Applying 
this estimate to WSJD results in a total loss between fertilisation and birth of 79%.
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B. Professor Nigel Andrew Brown
Munby J. quotes from Professor Brown’s witness statement 
(WSNB) only once: “It is striking that the usual fate of the 
fertilized egg is to die”q. Alone, this statement lacks quantitative 
rigour, since all fertilised eggs eventually die, the substantive 
issues being when and how many. However, immediately 
following this, in his witness statement, Professor Brown 
continues: 
 “The proportion of fertilized eggs that produce a live full-
term baby (in the absence of contraceptive measures) is not 
known precisely, but is probably only 40%1. The other 
60% die, at all stages from fertilization to late pregnancy. 
Perhaps 20% or so do not implant in the uterus; there are 
no systemic signs that fertilization has occurred, and the 
woman is unaware. The next common stage of conceptal 
death is soon after implantation, when the consequence can 
be a heavier than usual menstrual flow, perhaps somewhat 
delayed, which can be noticeable.”r
This passage, from a section entitled “The Incidence of Death 
of Fertilised Eggs”, contains all the quantitative information on 
human embryo loss in WSNB. 20% loss prior to implantation 
is similar to the value of 15% given by Drife. Total loss of 
60% from fertilisation to birth is close to Leridon’s estimate of 
63%. However, the study16 providing the source for the 40% 
has been misinterpreted: the 60%s loss in Edmonds et al. (1982) 
actually indicates embryo loss from implantation and not from 
fertilisation as stated by Brown. Unfortunately, the data in 
Edmonds et al. are likely to be substantially biased owing to 
sup-optimal experimental design and methodology5. As noted 
above, more and better studies had been published by 2001 and 
all reported substantially lower estimates of post-implantation 
embryo loss.
Thus, in summary: 
1.     As already noted, available scientific evidence on human 
embryo mortality is easily misread.
2.     Brown’s ball-park figure for mortality from fertilisation 
to birth of 60%, despite being based on a misreading of a 
technically biased study, is close to Leridon’s estimate 
of 63%. Both of these estimates are somewhat lower 
than Drife’s estimate of 75% loss before an apparently 
normal period.
3.     Brown’s estimate of 20% for pre-implantation loss is 
close to Drife’s (and Leridon’s) estimate of approximately 
15%.
C. Professor Peter Riven Braude
The interpretation of the evidence submitted by Professor 
Peter Braude is at the heart of the scientific misunderstanding 
in this case. Munby J. deliberately emphasises the extent of 
embryo loss as follows: 
 “There is one other aspect of this medical evidence which 
perhaps requires emphasis. This is summarised by Professor 
Braude in the proposition that “Fertilisation does not usually 
result in the development of an embryo” and by Professor 
Brown in the statement “It is striking that the usual fate of 
the fertilized human egg is to die.” According to Professor 
Braude not much more than 25% of successfully fertilised 
eggs reach the blastocyst stage of development and “Even 
once implanted the failure rate is prodigious”, for fewer than 
15% of fertilised eggs will result in a birth.”t
Professor Braude submitted to the court as evidence both a 
witness statement (WSPB) and a book chapter, entitled The 
Embryo in Contemporary Medical Science17, listed as Exhibit 
PB/2, jointly written and published in 1990 by him and a 
colleague, Professor Martin Johnsonu. The values emphasised 
by Munby J. in paragraph 129 of his judgment are from this 
book chapter. Braude does not use these values in his witness 
statement but merely states that “It is to be noted that of the 
eggs that are successfully fertilised, a large number do not 
eventually become implanted in the uterine wall.”v He provides no 
citation for this claim.
Unlike Drife and Brown, Braude cites the best available study of 
early pregnancy loss at that time, Wilcox et al. (1988)15, stating 
that “nearly one quarter (22%; 43/198) of women attempting 
pregnancy, showed a positive hCG but did not continue 
to miss their menstrual period or continue with a clinical 
pregnancy.”w Braude also refers to another study, albeit without 
an explicit citation; however, it is clear from the context that the 
study is Ellish et al. (1996)18. He reports a post-implantation 
embryo loss in this study of “between 11% and 27%”x 
prior to the first missed period. These values are from Table 
VI of Ellish et al. (1996), and are consistent with the equivalent 
value (22%) from Wilcox et al. (1988) and many other studies5. 
However, it is important to note that neither Wilcox et al. 
(1988), Ellish et al. (1996), nor the two similar studies cited by 
Drife (Miller et al., 1980) or Brown (Edmonds et al., 1982) 
contains any data on embryo loss between fertilisation and the 
onset of implantation.
Exhibit PB/2 is an extract from a book that examines the 
human embryo from historical, legal and cultural perspectives. 
q Munby [129]; WSNB [22].
r WSNB [22]. Footnote 1 in this passage reads as follows: “Edmonds D.K., Lindsay 
K.S., Miller J.F., Williamson E., Wood P.J. Early Embryonic Mortality in Women, 
Fertility and Sterility 1982 Vol 38 447–453”.
s The precise value reported by Edmonds et al. (1982) was 61.9%.
t Munby [129].
u It is both likely and appropriate that Munby J. would have regarded Professor 
Johnson also as a “very eminent medical expert”.
v WSPB [8].
w WSPB [15]. Braude’s description of this data is slightly inaccurate. The study 
followed 221 women who were attempting to get pregnant, and the value of 22% 
(43/198) actually refers to the number of hCG positive menstrual cycles (198 out of 
707 monitored cycles) that did not manifest as a clinical pregnancy, i.e., 43. 22% 
therefore refers to embryo loss from the onset of implantation (as indicated by the 
positive hCG test) up to, but not including, clinical diagnosis (as indicated by an 
absent menstrual period or subsequent positive pregnancy test).
x WSPB [15].
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It is a scientific chapter17 and its purpose is stated clearly in the 
introduction: “It is our intention here to summarize as simply 
as possible some of our current knowledge about human early 
development which can serve as a basis for informed discus-
sion.” It is a description of the formation of germ cells (sperm and 
ova), fertilisation, and the development and growth of the 
embryo up until birth. The principal focus is on the period 
from fertilisation up until the fetal stage, thereby reflecting the 
subject matter of the book as a whole. The account is very 
useful.
The values used by Munby J. in paragraph 129 are in one section 
of this chapter. Following Munby J.’s example, I shall quote the 
paragraph at length, underlining those phrases reproduced verbatim 
in his judgment: 
“Fertilization does not usually result in the development of 
an embryo. From our knowledge of human development 
in vitro and those limited studies of early human develop-
ment in vivo, it seems that not much more than 25 per cent 
of successfully fertilized eggs reach the blastocyst stage 
of development.16 Even once implanted the failure rate is 
prodigious. A recent study has suggested that 22 per cent 
of very early pregnancies which can be detected by raised 
blood levels of human chorionic gonadotrophin (hCG; the 
hormone produced by the implanting trophectoderm) will 
fail.17 This group does not include those pregnancies that 
fail before the hCG can be produced and thus go undetected. 
In addition, a further 12–15 percent of clinically recognized 
pregnancies fail within the first 4 months of pregnancy.18 
In all, fewer than 15 per cent of fertilized eggs will result in a 
birth.”y
This passage contains several quantitative claims. A 12–15% 
clinical loss is a credible estimate5. The reference to 22% is from 
Wilcox et al. (1988) and is followed by the important point, 
highlighted above, that those data do not include pregnancies 
that fail after fertilisation but before implantationz. In other 
words, that study, and by extension all studies that monitor 
pregnancy by detection of elevated hCG, cannot inform us 
about embryo mortality rates in the week after fertilisation but 
before implantation, that is, during the period that the MAP 
is typically used. The remaining two values in this passage, 
both reproduced in the judgment, namely, 25% survival from 
fertilisation to blastocyst, and fewer than 15% survival from 
fertilisation to birth, require further inspection.
Munby J. knew that the blastocyst stage is reached prior to the 
commencement of implantation as indicated by his account 
of the physiologyaa. Table 1 in Exhibit PB/217, which Munby 
J. appears to have read in detail, also makes it clear that the 
blastocyst stage is reached at 5 days, before implantation at 
7 days. Hence, it is clear that Braude & Johnson’s claim that 
“not much more than 25% of successfully fertilized eggs reach 
the blastocyst stage of development” is in stark contrast to 
that of Drife and Brown, that 15% or 20% of embryos are lost 
before implantation. According to one, only 25% survive, and 
according to the others, 80–85% survive to the blastocyst stage. 
This difference is substantial (Figure 1) and the inconsistency 
invites scrutiny. Did Munby J. notice this discrepancy in 
estimates of the same phenomenon occurring within a few 
paragraphs of his own judgment? Is it by chance that he chose to 
emphasise the one value from all the submitted evidence that 
maximised and exaggerated the extent of embryo mortality 
prior to implantation, precisely the time when the MAP is 
intended for use? It may be stated that if Munby J. believed that 
this value referred to the mortality of embryos in vivo under 
natural conditions, conditions under which the MAP is typically 
used, he was unequivocally wrong.
The basis for his error is not difficult to identify and will be 
clarified after considering the evidence provided by the fourth 
expert witness.
D. Dr John McLean
Dr McLean provided the longest written statement (WSJM1) 
of all the expert witnesses (Table 1). Specifically, his statement 
included a section entitled “Early Embryo Loss”bb comprising 
740 words and 10 scientific references. (McLean provided a 
second witness statement (WSJM2), which addressed the issue 
of the dating of the commencement of pregnancy. It contains no 
additional information on human embryo mortality.) McLean 
distinguishes between different categories of study on embryo 
loss: those that, in principle, provide information on embryo 
loss before implantationcc, and those that provide information 
on loss only after implantation has commenceddd. In the first 
category, McLean discusses in some detail the unique studies 
of Hertig previously mentioned10. As noted with Drife and 
Brown, there are minor errors in McLean’s account. For 
example, 42 is not the maximum age of the 210 women enrolled 
in the study, but the maximum age of those 34 women from 
whom fertilised ova were recovered. More importantly, he 
gives three strikingly variant summary values for early embryo 
loss derived from Hertig: 29%, 35% and 78%.
McLean’s first value of 29% is his own calculation derived 
from the 10 abnormal embryos found by Hertig out of all 34 
embryos recovered (10/34 = 0.29). Hertig does not use this 
value nor such a calculation. Making sense of Hertig’s data 
and calculations is not straightforward, although it is clear that 
y Braude & Johnson (1990), p. 218. The passage contains three endnotes as follows:
Endnote 16 reads: “V. N. Bolton, and P. R. Braude, in A. McLaren and G. Sira-
cusa, eds, Current Topics in Developmental Biology, Vol 23, Recent advances in 
mammalian development, Academic Press, 1987, pp. 93–114.”
Endnote 17 reads: “A. J. Wilcox, C. R. Weinberg, J. F. O’Connor, D. D. Baird, J. P. 
Schlatterer, R. E. Canfield, E. G. Armstrong and B. C. Nisula, Incidence of early loss 
of pregnancy’, New Eng. J. Med., 319, 1988, 189–94.”
Endnote 18 reads: “L. Regan ‘A prospective study of spontaneous abortion’, in: R. W. 
Beard and F. Sharp, eds, Early Pregnancy Loss, 18th Study group of the Royal College 
of Obstetricians and Gynaecologists, Springer-Verlag, 1987, pp. 23–37.”
z Given the matter under consideration in the judicial review, it is notable that, in 
this passage, Braude & Johnson clearly use the word ‘pregnancies’ to refer to women 
carrying a fertilised egg before implantation.
aa Munby [126(vii)] & [126(viii)].
bb WSJM1 [30–34].
cc WSJM1 [31] & [33].
dd WSJM1 [32].
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only 8 of the 34 embryos recovered by Hertig were at a pre- 
implantation stage. An attempt to clarify his calculations has 
recently been published5, and argues that Hertig’s data and 
analytical logic indicate that 50%ee of fertilised eggs would 
perish up to the time of a missed menstrual period, and that 
30% would perish between fertilisation and implantationff. 
Leridon’s equivalent values are 50% and 18%. McLean’s 
second value, 35%, comes from a re-interpretation of Hertig’s 
data by James (1970)19. However, James’ value of 35% refers 
to loss of all fertilised eggs before the first missed period 
and not just before implantation. Hence, James’ estimate is 
less than both Hertig’s and Leridon’s for the first two weeks 
after fertilisation, and he concludes that “49% of all zygotes 
perish naturally between fertilization and confinement”gg. 
McLean’s third value of 78% is from Roberts & Lowe’s 
Lancet article12. Roberts & Lowe cite Hertig’s work in sup-
port of their quantitative argument although it is unclear how it 
meaningfully informs their analysishh. Furthermore, Roberts & 
Lowe’s 78% estimate is not for early pregnancy loss, but for 
embryo loss from fertilisation to birth. Though widely cited, it is 
both exaggerated and unsupported by evidence.
In giving the impression that Roberts & Lowe’s estimate is 
derived from Hertig’s data, McLean’s account is inaccurate 
and unhelpful. Nevertheless, such a large numerical variance 
might alert an attentive reader to the difficulties associated with 
detecting pre-implantation human embryos, an issue McLean 
explicitly discussesii. In paragraphs 23–25 of WSJM1, he 
considers two putative biological markers, early pregnancy 
factor (EPF) and embryo-derived platelet activating factor 
(EDPAF), that had been proposed to be released within 24 hours 
of fertilisation. He discusses the possibility that detection of 
EDPAF might provide insight into the fate of embryos in the 
first weekjj; however, he offers no quantitative estimates from 
such investigations. Since 2001, little work has been published 
on EPF or EDPAF and any initial promise they may have had 
for detecting pre-implantation embryos has long since fadedkk. 
Munby J. was correct in stating that “The test for hCG repre-
sents the first reliable opportunity to identify the existence of an 
embryoll.”
WSJM1 also contains results from three studies that used the 
detection of hCG to quantify embryo loss between implan-
tation and a clinical diagnosis of pregnancy. The estimates 
were 33%13, 57%16 and 8%20 early pregnancy loss. Once again, 
the divergence in these values is striking and may make a 
thoughtful reader query their reliability. The high variance 
in the results from these three studies is likely to be due to 
limitations in experimental reagents and study design5. Given 
the length and detail of his statement, it is surprising that 
McLean does not mention Wilcox et al. (1988), the first of 
several studies to address these limitations. Nevertheless, 
McLean does make it clear that even these studies cannot, in 
principle, provide information on the fate of the pre-implantation 
embryo.
McLean also makes the important point that the extent of 
early embryo loss is not only a matter of biological interest, but 
“has acquired political significance with regard to legislation 
on human embryo experimentation and the use of emergency 
hormonal contraception”mm. Arguably, Munby J.’s emphasis 
on this aspect of the scientific evidence lends credence to this 
point. McLean continues: “It is therefore important to obtain as 
accurate an estimate as is possible for the occurrence of early 
human embryo loss.” As if to reinforce this point, he cited 
a study by Walker et al. (1988)21 that reported no losses of 
biochemical pregnanciesnn in 75 cycles and concluded that the 
extent of early pregnancy loss may have been “substantially 
overestimated.”oo This estimate of 0% loss is extreme, and a 
reasoned response from Wilcox argued that the results of their 
two studies were not necessarily inconsistent22. However, the 
message is clear: quantification of early embryonic loss gen-
erates confusing and highly variable results and it therefore 
behoves a cautious reader concerned with factual accuracy to 
scrutinise specific quantitative claims with care.
In emphasising that “not much more than 25% of successfully 
fertilised eggs reach the blastocyst stage”, a value that is 
quantitatively contradicted by the evidence provided by Drife, 
Brown and McLean (Figure 1), Munby J. reveals that he did 
not properly understand the significance of the expert witness 
evidence provided to the court on this matter. Furthermore, he 
cannot have examined that particular claim with due care, for 
if he had done, he would have discovered why the value was 
so low and why it was of no relevance to the case.
Munby J.’s error
In paragraph 129 of Munby J.’s judgment there are two 
quantitative claims, both attributed to Professor Braude, 
that invite close scrutiny: (1) “not much more than 25% of 
successfully fertilised eggs reach the blastocyst stage of 
development”, and (2) “fewer than 15% of fertilised eggs will 
result in a birth”. Although Munby J. does not place these 
statements in quotation marks, they are taken directly from the 
ee This value of 50% ultimately derives from the 8 pre-implantation embryos, of 
which 4 were abnormal and therefore assumed to be destined to perish before the 
end of the first 2 weeks after fertilisation. It is therefore based on a very small sample 
size.
ff It is a numerical coincidence that McLean’s value of 29% (10/34) is so close to 
this value of 30%.
gg A zygote is the newly fertilised ovum: a one-cell embryo. Confinement is the 
time of childbirth.
hh For example, Roberts & Lowe use Hertig’s work as a source for their claim that 
coitus at the time of ovulation results in a fertilisation rate of 50%. This contrasts 
with Hertig’s own conclusion, followed by Leridon, that ‘when conditions are 
optimal about 15 per cent of oocytes fail to become fertilized’ (Hertig, 1967).
ii WSJM1 [33].
jj WSJM1 [33].
kk A PubMed (https://www.ncbi.nlm.nih.gov/pubmed) search on <”early preg-
nancy factor”[All Fields] NOT Review[ptyp]> performed on 3rd June 2020 
identified 142 articles published between 1977 and 2000, and 35 from 2001 
to the present day. A search on <“embryo derived platelet activating factor” 
[All Fields]> identified only 26 articles, published between 1985 and 2004. Only 
two of these were published after 1992. 
ll Munby [126(ix)].
mm WSJM1 [34].
nn “Biochemical pregnancy”: this term is sometimes used to refer to pregnancies that 
are detected solely by elevated hCG rather than by clinical observations such as a 
missed menstrual period.
oo This phrase is found both in WSJM1 [34] and the abstract of Walker et al. (1988).
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book chapter submitted by Braude as evidence (Exhibit PB/2)17. 
In this chapter, the 25% claim is supported by a citation to a 
review on the early development of human embryos in vitro 
co-written by Dr Virginia Bolton and Professor Braude23. A 
“<15%” claim is found in the same review.
Bolton & Braude’s review of the development of the preimplan-
tation human embryo in vitro represents IVF as “a remarkably 
inefficient therapeutic procedure” and explores biological and 
technical reasons for the “unacceptably high rate of embryonic 
loss” associated with IVF treatment. Within this context they 
describe the work of Fehilly et al. (1985)24 who… 
 “…attempted to culture human embryos surplus to those 
required for replacement during therapeutic IVF cycles to 
the blastocyst stage for cryopreservation. Of 784 pronucle-
ate embryos, 75% (585) were able to develop to the five- to 
eight-cell stage in vitro; only 34% (197) of these progressed in 
culture to form expanded blastocysts.”
197 expanded blastocysts developing from 784 embryos is 
25.1%, i.e., “not much more than 25%”.
Fehilly et al. (1985) conducted their study primarily to deter-
mine whether embryos frozen at the cleaving stage (day 3–4 
after fertilisation) or at the blastocyst stage (day 5–6 after 
fertilisation) would be more effective at producing subsequent 
pregnancies after embryo thawing and transfer into the womb. 
Based on the data described above, with regard to embryo 
development to the blastocyst stage, they commented that “only 
one quarter of them expanded in vitro”. This data is the source 
for Munby J.’s claim that not much more than 25% of fertilised 
eggs reach the blastocyst stage.
In the following paragraph in their review, Bolton & Braude 
offer one reason for the low survival rate of the in vitro embryos: 
“Suboptimal culture conditions are undoubtedly responsible for 
a proportion of this embryonic failure”23. Elsewhere, Braude 
reports that “Experiments in our laboratories have suggested 
that the in vitro handling of oocytes can produce chromosomal 
aberrations at alarmingly high frequencies”25 and strikingly, 
that “When Bob Edwards and indeed my own group were 
researching these early stages, blastocyst culture was awful 
(about 15% of embryos made it to that stage)”26. More recently, 
Dr Bolton has repeated that “Embryo culture conditions in vitro 
are likely to be suboptimal compared with those in vivo”27. Put 
simply, human embryos created by fertilisation in vitro did not, 
and do not fare well. Hence, the use of in vitro data to define 
the fate of natural embryos in vivo is both biologically and 
quantitatively risky5.
Munby J.’s second quantitative claim, that “fewer than 15% of 
fertilised eggs will result in a birth”, also comes from Bolton 
& Braude’s review via Braude & Johnson’s chapter. A further 
quotation from p. 93 makes the point: 
 “In fact, IVF represents a remarkably inefficient therapeu-
tic procedure. Although fertilization can now be achieved 
with consistent success in vitro, the success rate of ongoing 
pregnancies is much lower … If an average is taken from the 
longest established IVF units, it can be seen that <15% of all 
embryos that are replaced will result in a clinical pregnancy 
(Table I).”23
Table I in Bolton & Braude provides a quantitative summary 
of the success of embryo replacement using data from seven 
clinical IVF units. The data are sub-divided according to 
whether 1, 2 or 3 embryos were replaced (i.e., transferred) into 
the womb of the woman undergoing treatment. The clinical 
pregnancy rate among the patients thus treated is reported as 
a percentage of embryos replaced as 12.7%, 12.1% and 9.6% 
respectively. These values are somewhat lower than 15% and 
clearly refer to clinical pregnancies. Nevertheless, this IVF data 
appears to be the source for the judicial claim that “fewer than 
15% of fertilised eggs will result in a birth”.
There are only two other cited studies in the key paragraph of 
Braude & Johnson’s chapter (Exhibit PB/2)17. These are the 
study by Wilcox et al.15 and a paper by Professor Lesley Regan28. 
Wilcox et al. conclude that “The total rate of pregnancy loss 
after implantation, including clinically recognized spontaneous 
abortions, was 31 percent” and a re-analysis of that data 
suggests that approximately 50% of the fertilised eggs in that 
study may have been lost up to birth4. Regan’s paper addresses the 
incidence of spontaneous abortion of clinical pregnancies with 
a focus on recurrent abortion. It contains preliminary findings 
from a prospective study of pregnancy loss and, interestingly, 
concludes that the “overall incidence of spontaneous abortion 
in this prospective study is considerably lower than those reported 
in previous studies (10.3% overall; 5.6% for primigravidae)”28. 
Therefore, neither Wilcox et al. (1988) nor Regan (1987) is a 
credible source for Munby J.’s claim that “fewer than 15% of 
fertilised eggs will result in a birth”.
It is clear therefore that the two values emphasised by Munby 
J. in his judgment referred firstly, to embryo mortality in vitro, 
and secondly, to the survival of IVF embryos following their 
transfer into women as part of fertility treatment. It is surely 
reasonable to suppose that the context for the use of the MAP, 
subject to the judicial review, was not in vitro embryos in a 
laboratory or women undergoing fertility treatment, but rather 
naturally conceived embryos and women at risk of pregnancy. 
The values emphasised by Munby J. have no bearing on the 
case at all.
An understandable error?
It is charitable to assume that Munby J. did not realise that the 
figures he emphasised were biologically misrepresentative and 
therefore irrelevant to the case. Nevertheless, are there any 
reasons to believe that he could have spotted and avoided this 
error?
There are clues in Braude & Johnson’s chapter that might alert 
an attentive reader to the potentially misleading nature of some 
of its quantitative claims. In the introduction, they explicitly 
state that their knowledge of human development was drawn 
from various sources, including “studies of live preimplan-
tation pre-embryos in vitro as part of therapeutic infertility 
programmes”, and in the critical paragraph from which Munby 
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J. quotes, they preface their remarks with the phrase: “From our 
knowledge of human development in vitro and those limited 
studies of early human development in vivo”. Unfortunately, 
their subsequent commentary does not make it clear which of the 
evidence they report is from in vivo, and which from in vitro 
studies. Scrutiny of the references, as noted above, is revealing. 
Since Braude & Johnson aimed “to summarize as simply as 
possible some of our current knowledge about human early 
development”, it is perhaps understandable that they glossed over 
such detail. Consequently, a non-expert reader may be forgiven 
for concluding that their account related to normal early human 
development under natural conditions, particularly since no 
indication is given in the chapter that there are any substantive 
differences between in vitro and in vivo embryonic development.
It is unlikely that Braude & Johnson wrote the chapter, 
published in 1990, with a view to it being submitted as expert 
witness testimony in a judicial review in 2001, let alone that it 
should be directly quoted by a judge. Perhaps it would have 
been wise only to submit a contemporaneous witness statement 
addressing matters of direct relevance to the case. It would be 
harsh to even hint that, in submitting the chapter as expert 
witness evidence, Braude intended to mislead the judge on 
this particular matter, and it may be asking too much to expect 
even a learned judge to see through such a tangle of scientific 
evidence. Nevertheless, irrespective of whether witness, judge or 
both were culpable, the outcome is clear: Munby J. misjudged 
the extent of human embryo mortality.
Munby J. had more evidence available to him than just Braude & 
Johnson’s chapter (Table 1). The emphasis he placed on 
human embryonic mortality must therefore be read in the 
context of that further expert witness testimony. Arguably, the 
contradictions between the various statements (see Figure 1) 
should have alerted him to these issues. Other than to acknowl-
edge its existence, Munby J. makes no reference to McLean’s 
detailed and lengthy statement, prepared on behalf of the 
Claimant. This is regrettable, since the statement offers 
credible warnings about the relevance and reliability of estimates 
of embryo mortality in the scientific literature. The similar numerical 
estimates for pre-implantation loss offered independently by 
both Drife and Brown are in stark contrast to the one he chose to 
emphasise from Braude & Johnson’s chapter. Furthermore, in 
selectively weaving quotations from the witness testimonies, 
Munby J. gives the misleading impression that Braude and 
Brown were in agreement about the extent of early embryo 
mortality, despite evidence to the contrary.
One is left wondering whether Munby J. realised what he was 
doing.
Conclusion
Braude & Johnson’s chapter was written with more than just 
biology in mind: the critical paragraph is in a section headed 
“Ethics and the biology of pre-embryos” and the conclusion 
touches on religious, ethical and regulatory issues. It thus 
appears that there was an ethical and, by extension, a legislative 
agenda underlying this chapter. This agenda is more explicit in a 
magazine article29 cited by Braude & Johnson.
Natural human embryo mortality has often been linked to the 
ethical status of human embryos. For example, in their brief 
article, Roberts & Lowe state that “If Nature resorts to abor-
tion … by discarding as many as 3 in every 4 conceptions, it 
will be difficult for anti-abortionists to oppose abortion on 
moral and ethical grounds.”12 Ronald Green, Professor Emeritus 
of Religion at Dartmouth College, points out, incorrectly, that 
“between two-thirds and three-quarters of all fertilized eggs 
do not go on to implant in the womb” and asks: “In view of this 
high rate of embryonic loss, do we truly want to bestow 
much moral significance on an entity with which nature is so 
wasteful?”30 A report of the Ethics Committee of the Royal 
College of Obstetricians and Gynaecologists in 1983 states: 
“Knowing as we do that in the natural process large num-
bers of fertilised ova are lost before implantation, it is morally 
unconvincing to claim absolute inviolability for an organism 
with which nature itself is so prodigal”31. This link has been 
considered by many others32–34. Thus, McLean’s assertion, 
in evidence, that early embryo loss is not only of biological 
interest but also of political and legislative significancepp, was 
clearly correct. How specific estimates of embryo mortality 
inform an ethical calculus is, perhaps, not so clear. Neverthe-
less, for those who consider it germane, McLean’s exhortation 
that “It is therefore important to obtain as accurate an estimate 
as is possible for the occurrence of early human embryo loss”, 
must surely be correct too.
Did the quantitative bias in Munby J.’s description of embryo 
mortality have a significant influence on his legal judgment? 
If not, why then, one may ask, in such a “very long” 
judgment, would he deliberately choose to emphasise this 
particular point? What purpose might such an observation serve? 
Perhaps these are questions for other, legal minds. However, the 
biology is a different matter. Judgments carry weight and can 
influence opinion. Even on biological matters, legal scholars 
may rely upon the sayings of learned judges rather than scientific 
evidence.
In the first four editions of her popular undergraduate 
textbook35–38, Emily Jackson discusses Munby J.’s judgment 
and comments on embryo loss: “Approximately 75 per cent 
of all naturally fertilized eggs will be lost before the woman’s 
next period, and it would be counterintuitive to describe these 
losses as miscarriages”qq. Although she does not offer the 
judgment as her source, her words closely reflect Drife’s 
evidence, repeated verbatim in the judgmentrr. Her addition of 
the word “naturally” makes explicit the implied, and incorrect, 
sense in the judgment. It is notable that in the most recent 
(2019) edition of her book39 the explicit 75% claim is omitted: 
“The majority of naturally fertilized eggs will be lost before the 
pp WSJM1 [34].
qq Jackson, E., Medical Law: Text, Cases, and Materials. 1st ed. (2006), p. 624; 2nd ed. 
(2010), p. 693; 3rd ed. (2013), p. 703; 4th ed. (2016), p. 737.
rr “…around 75% of all conceptions are followed by an apparently normal period. 
These losses … are not covered by the term ‘miscarriage’.” from WSJD [8] and Munby 
[134].
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woman’s next period, and it would be counterintuitive to 
describe these losses as miscarriages.”ss
Another legal scholar, Jonathan Herring, in all eight editions 
of his textbook40–47, quotes directly from paragraph 129 of 
Munby J.’s judgment in order to outline an ethical argument: 
“Those who disagree with the argument that personhood 
begins at conception … could also make the following 
argument: ‘[It] is striking that the usual fate of the fertilized 
human egg is to die.’† It has been estimated that fewer than 15 
per cent of fertilized eggs will result in a birth.§”tt
The first reference (†) correctly attributes these words to 
Professor Brown, as found in the judgment. Strangely, the 
second reference (§) is to an article by Professor John Harris 
on assisted reproductive technological blunders48 that has no 
bearing on the issue. Clearly, it is a direct quotation from Braude 
& Johnson (1990)17 and paragraph 129 of Munby J.’s judgment.
It is unfortunate that these biological errors have found their 
way into standard legal textbooks. Irrespective of the philo-
sophical merits of arguments such as those outlined above, 
most would agree that in order to arrive at defensible ethical 
and legal conclusions it is necessary to begin with reliable and 
relevant evidence. It would be helpful if Munby J. were to 
clarify whether he realised that the numerical estimates he 
emphasised in paragraph 129 of his judgment were derived from 
in vitro circumstances, and were therefore not representative 
of natural in vivo situations. It would also be instructive to 
know whether Munby J. still believes that “not much more than 
25% of successfully fertilised eggs reach the blastocyst 
stage of development”. If the answers to these queries are 
negative, a clarification from him regarding the biology would 
be welcome, in the hope that the widely held, unsubstantiated 
and excessively pessimistic view of natural human embryo 
survival may, little by little, be replaced with one that is more 
closely based on available, relevant, scientific evidence5.
Data availability
Underlying data
Apollo - University of Cambridge Repository: Underlying-
Data_MisjudgingEarlyEmbryoMortality_Redacted, https://doi.
org/10.17863/CAM.536963
This dataset consists of transcripts of scientific witness 
statements submitted as evidence in R (on the application of 
Smeaton) v Secretary of State for Health [2002] EWHC 610 
(admin) (18 April 2002) (Case No: CO/928/01). Some content 
has been redacted, including personal addresses.
Copyright (“all rights reserved”) for the content of the witness 
statements remains with the authors of the statements.
Photocopies of original expert witness statements were obtained 
from the archives of the Claimant. A full unredacted (except for 
personal addresses) transcript and copies of the statements are 
available from the author on request.
ss Jackson, E., Medical Law: Text, Cases, and Materials. 5th ed. 
(2019), p. 770.
tt Herring, J., Medical Law and Ethics. 1st ed. (2006), p. 250; 2nd ed. 
(2008), p. 285; 3rd ed. (2010), p. 310; 4th ed. (2012), p. 318; 5th ed. 
(2014), p. 320; 6th ed. (2016), p. 332; 7th ed. (2018), p. 331; 8th ed. 
(2020), p. 374.
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